• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON INC. STFX SYM PDS+ UNI VIO 24IN 1 S/A CTX; SUTURE, SURGICAL, ABSORBABLE, POLYDIOXANONE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON INC. STFX SYM PDS+ UNI VIO 24IN 1 S/A CTX; SUTURE, SURGICAL, ABSORBABLE, POLYDIOXANONE Back to Search Results
Model Number SXPP1A445
Device Problems Break (1069); Material Frayed (1262)
Patient Problems Pain (1994); Loss of Range of Motion (2032)
Event Date 10/02/2021
Event Type  Injury  
Manufacturer Narrative
(b)(4).This is a combination product, and the event has been reviewed for both the suture and the triclosan.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Trade name - irgacare®, active ingredient(s) ¿ triclosan, dosage form ¿ suture/solid/parenteral, strength ¿ = 2360 ug/m all others.(b)(4).To date the device has not been returned.If the device or further details are received at a later date a supplemental medwatch will be sent.Attempts are being made to obtain the following information.To date no response has been provided.If further details are received at a later date a supplemental medwatch will be sent.Please provide the patient's demographic information including gender and bmi at the time of index procedure on what tissue was the suture used? what was the tissue condition (normal, thin, calcified, fragile, diseased)? did surgeon change any pre-op, intra-op or post -op surgery regimen? were there any pre-existing signs/symptoms of active inflammation/infection prior to this surgical procedure? other relevant patient history/concomitant medications? what is the lot number? was the fixation tab seated against the tissue at the initiation of suture use during the index procedure? how was the incision done, please specify.Was it curvilinear or straight? were two reverse stitches performed across the incision prior to closure? did the operating surgeon observe any suture deficiency or anomaly before or during suture placement? what instruments were used in this procedure to handle the suture? was there a precipitating stress factor for the post-op suture breaking/fraying? was there a wound dehiscence? was the tissue torn around the suture closure? what is the physician¿s opinion as to the etiology of or contributing factors to these events? what is the patient's current status?.
 
Event Description
It was reported that the patient underwent a right total knee arthroplasty on : (b)(6) 2021 and barbed suture was used.The suture was placed bottom to top and backed stitched twice as per ifu.It was confirmed no extra tension was placed.There were no needle drivers used for handling suture.The knee was closed at flexion from 70-90 degrees.On (b)(6) 2021, the patient had an office visit with complaints of r knee pain, loss of 25 degrees rom/strength, palpable defect along the superior medial patellar border.On (b)(6) 2021, the patient underwent an open repair r knee medial retinaculum.It was clarified that the suture not only broke in the middle, but that the suture delaminated/frayed in 1 point at the middle of the closure line.The sales rep stated the middle of the suture looked frayed/unraveled.It split longitudinally.Additional information has been requested.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STFX SYM PDS+ UNI VIO 24IN 1 S/A CTX
Type of Device
SUTURE, SURGICAL, ABSORBABLE, POLYDIOXANONE
Manufacturer (Section D)
ETHICON INC.
1000 route 202
raritan NJ 08869
Manufacturer (Section G)
ETHICON INC.-JUAREZ
avenida de las torres 7125
col salvacar
ciudad juarez 32604
MX   32604
Manufacturer Contact
elba bello
1000 route 202
raritan, NJ 08869
MDR Report Key12920804
MDR Text Key281733060
Report Number2210968-2021-12304
Device Sequence Number1
Product Code NEW
UDI-Device Identifier10705031245273
UDI-Public10705031245273
Combination Product (y/n)Y
Reporter Country CodeUS
PMA/PMN Number
K141776
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility,Company Representative
Reporter Occupation Other
Type of Report Initial
Report Date 12/02/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberSXPP1A445
Device Catalogue NumberSXPP1A445
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 11/09/2021
Initial Date FDA Received12/02/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age51 YR
Patient Weight59 KG
-
-